Schering/IBA set up UK PET (positron emission tomography) imaging radiotracer company:
This article was originally published in Clinica
Schering AG's UK business, Schering Health Care, has teamed up with IBA of Belgium to form a new UK company for the supply of a positron emission tomography (PET) imaging radiotracer. UK Radiopharma will be the country's first commercially licensed supplier of F-18 fluodeoxyglucose (FDG), which it will sell as Flucis. Market launch is expected by 2005. Schering AG and IBA (which already sells FDG in the US) plan eventually to create a European network of FDG production sites. FDG is the most commonly used radioactive tracer used in PET imaging for cancer diagnosis and treatment monitoring.
You may also be interested in...
Butterfly Network chose SPAC route with Longview Acquisition Corp. to scale its business and expand into the home market in 2021.
Regulatory review resource-intensive cell and gene therapy licensing applications are rolling toward US FDA along expedited pathways, while complete response letters and missed goal dates start to stack up under pandemic inspection constraints.
With Warp Speed Decisions Already Made, Transitioning To Biden Admin Should Be No Trouble, Slaoui Says
As vaccines near availability, Moncef Slaoui says his full-time role at OWS may be ending. He has not met with the Biden Transition team, but notes that other Warp Speed officials have.